Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.

Abstract

Background: A recently published randomized controlled trial compared single-dose psilocybin with single-dose niacin in conjunction with psychotherapy in participants with cancer-related psychiatric distress. Results suggested that psilocybin-assisted psychotherapy facilitated improvements in psychiatric and existential distress, quality of life, and spiritual well-being up to seven weeks prior to the crossover. At the 6.5-month follow-up, after the crossover, 60–80% of participants continued to meet criteria for clinically significant antidepressant or anxiolytic responses. Methods: The present study is a long-term within-subjects follow-up analysis of self-reported symptomatology involving a subset of participants that completed the parent trial. All 16 participants who were still alive were contacted, and 15 participants agreed to participate at an average of 3.2 and 4.5 years following psilocybin administration. Results: Reductions in anxiety, depression, hopelessness, demoralization, and death anxiety were sustained at the first and second follow-ups. Within-group effect sizes were large. At the second (4.5 year) follow-up approximately 60–80% of participants met criteria for clinically significant antidepressant or anxiolytic responses. Participants overwhelmingly (71–100%) attributed positive life changes to the psilocybin-assisted therapy experience and rated it among the most personally meaningful and spiritually significant experiences of their lives. Conclusion: These findings suggest that psilocybin-assisted psychotherapy holds promise in promoting long-term relief from cancer-related psychiatric distress. Limited conclusions, however, can be drawn regarding the efficacy of this therapy due to the crossover design of the parent study. Nonetheless, the present study adds to the emerging literature base suggesting that psilocybin-facilitated therapy may enhance the psychological, emotional, and spiritual well-being of patients with life-threatening cancer.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881119897615

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

13 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 69 references

Research works printed but not linked: 6

  1. American Psychiatric Association, 2000, Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR
  2. Kissane DW, 2000, Aust Fam Physician, 11, 1022
  3. Pahnke WN, 1969, Curr Psychiatr Ther, 9, 144
  4. Quek KF, 2004, Med J Malaysia, 59, 258
  5. Snaith RP, 1994, The Hospital Anxiety and Depression Scale with the irritability-depression-anxiety scale and the Leeds Situational Anxiety Scale: Manual
  6. Spielberger CD, 1983, Manual for the State-Trait Anxiety Inventory (Self- Evaluation Questionnaire)

Cited by

See all 360

Metadata

Authors
Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S.
Affiliations
  • Palo Alto University (US)
  • NYU Langone Health (US)
  • New York University (US)
  • Yale University School of Medicine, New Haven, CT, USA
  • University of Colorado Anschutz (US)
Corresponding author
Agin-Liebes, Gabrielle I
Venue
Journal of Psychopharmacology
Published
2020-01-09
Volume
34
Issue
2
Pages
155-166
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W3000636165
Cited by
360
References
69
Citations by year
2026: 45 · 2025: 66 · 2024: 66 · 2023: 62 · 2022: 54 · 2021: 49 · 2020: 17
FWCI
18.21
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Source Research Foundation
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Health › Religion, Spirituality, and Psychology
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
psilocybin-assisted therapy, existential suffering, anxiety, depression, hopelessness, demoralization, fear of death, long-term follow-up, spiritual well-being
MeSH terms
Psychological Distress, Adult, Aged, Combined Modality Therapy, Existentialism, Female, Follow-Up Studies, Hallucinogens, Humans, Male, Middle Aged, Neoplasms, Psilocybin, Psychotherapy, Time Factors, Treatment Outcome, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. https://app.cochat.ai/papers/10.1177/0269881119897615
The paper
Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020). Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. Journal of Psychopharmacology. https://doi.org/10.1177/0269881119897615

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.